CD226 and neoplasm: In delineating the mechanisms involved in DNT-mediated anti-tumor activities, we found that blockade of NKG2D, DNAM-1 and TRAIL differentially reduced the ability of DNTs to kill different lung cancer cells (Fig. 4a).